Front Page
August 6, 2026
7-OH: What is it? Why do people use it? What medical approaches can help?
Caleb Banta-Green, PhD, MPH, MSW; Mark Duncan, MD; Chris Buresh, MD, MPH; Maureen Oscadal, RN, MPH; Tom Hutch, MD; Mandy Sladky, MSN, RN Key points We encourage people who have questions about 7-OH to talk to their healthcare provider and we encourage providers to call our Psychiatry Consult Line if they have any questions. —…
July 22, 2026
ADAI/SOR Webinar: Involuntary SUD Treatment in Washington: When & How? (August 5, 2026, 12-1:30pm PT)
The State Opioid Response (SOR) team at ADAI has been hosting an ongoing series called “Frontline Conversations: Advancing SUD Care in Clinical Practice,” which explores emerging practices in the care of people living with substance use disorder (SUD). In their third session, August 5, 2026 (12-1:30pm PT), they’ll be discussing Involuntary SUD Treatment in Washington…
July 17, 2026
ADAI Small Grants: Fall Cycle is Open; Apply by September 9, 2026!
ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants research program, which awards funds to UW researchers for pilot studies and developmental research. Applications for the fall cycle are now being accepted; apply by 5pm PT September 9, 2026! Research funded through the small grants program has…
July 13, 2026
REGISTRATION OPEN: First Responder Wellness Summit (September 23, 2026)
Caring for Ourselves During the Overdose CrisisSeptember 23, 2026 | 8:00am-3:45pm PT | Register here Location: The Hub Ballroom at the University of Washington | 4001 E. Stevens Way NE, Seattle, WA First responders regularly face complex, high-impact situations that can take a toll over time, particularly as calls around substance use and drug overdose have…
July 10, 2026
ATTC/CTN Webinar July 29: Advising Patients on Buprenorphine Treatment Duration for Opioid Use Disorder (1.5 CME/CE available!)
Buprenorphine is a life-saving treatment for opioid use disorder, yet many people stop treatment earlier than recommended, either by choice or because they face barriers to ongoing care. In this webinar, sponsored by the Northwest ATTC, Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network, experts Ingrid Binswanger, MD, MPH,…
July 2, 2026
Sen. Maria Cantwell (D-WA) Announces New Integrated Behavioral Health Center Modeled After Work of ADAI’s Caleb Banta-Green, PhD
U.S. Senator Maria Cantwell (D-WA) joined community leaders in Spokane, WA, this week for a ceremonial groundbreaking of a new integrated behavioral health center being spearheaded by Frontier Behavioral Health (FBH) and the Community Health Association of Spokane (CHAS Health). Sen. Cantwell secured $2 million through the Health Resources and Services Administration (HRSA) to construct…
June 30, 2026
2026 ADAI Symposium on Cannabinoid Hyperemesis Syndrome (Sept. 18): Registration & Call for Poster Abstracts Open!
The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream September 18, 2026 | 9:00am – 4:00pm PT Attend virtually or in person at the UW Tower Auditorium. View program | Register | Submit abstract for a digital poster (due Aug 18) Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance. In a recent survey of Washington…
June 18, 2026
ADAI’s Mary Hatch & Inga Manskopf Recognized by Department for Professional Excellence
We are proud to announce that two of our team were recently recognized by our department (UW Psychiatry & Behavioral Sciences) for their excellent work! ADAI Associate Professor Mary Hatch, PhD, was awarded the Wayne J. Katon Outstanding Research Mentor Award, which recognizes a faculty member who has demonstrated excellence in research mentoring of faculty…
June 17, 2026
CEDEER Handout: Cutting Back on Stimulants with Contingency Management
Contingency management (CM) is an evidence-based intervention that can help people quit or cut back on stimulants, including methamphetamine and cocaine. This one-page handout was created by the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) to help educate patients or clients about this treatment option. The handout includes information on: More information…
June 16, 2026
Congratulations to our Spring ADAI Small Grant Awardees!
What are ADAI Small Grants? ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants Program, which awards funds to UW researchers for pilot studies and developmental research. The scope ranges from pharmacology of drugs to studies of clinical treatment strategies, prevention, and social policy issues….
Next page
